NCT01779557

Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate

The Prospective, Randomized, Parallel, Controlled, Multi-center Clinical Study of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 750 (actual)
• Sponsor: Chinese PLA General Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the effectiveness and safety of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate, investigate the proper dialysis dose for Chinese CAPD patients.

Detailed description

This study is a prospective, randomized, parallel, controlled, multi-center clinical study of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate.It aims to investigate the proper dialysis dose for Chinese CAPD patients.At the same time,it can evaluate the effectiveness and safety of Chinese product Huaren Peritoneal Dialysate and peritoneal dialysis product Baxter Peritoneal Dialysate.

Conditions

• Kidney Failure,Chronic

Interventions

Type	Name	Description
DRUG	Huaren Peritoneal Dialysate	Huaren Peritoneal dialysate CAPD 3-5 times/d
DRUG	Baxter Peritoneal Dialysate	Baxter Peritoneal dialysate CAPD 3-5 times/d

Timeline

• Start date: 2013-02-01
• Primary completion: 2019-10-01
• Completion: 2021-09-01
• First posted: 2013-01-30
• Last updated: 2022-03-10

Locations

1 site across 1 country: China